Plasma Apolipoproteins A-I And B In Survivors Of Myocardial Infarction And In a Control Group (Lipids and Lipoproteins‪)‬

Several epidemiological studies have confirmed that coronary heart disease (CHD) is associated with lipid abnormalities [1, 2], and intervention studies have demonstrated that a reduction of total and LDL-cholesterol (LDL-C) and an increase of HDL-cholesterol (HDL-C) decrease the risk of CHD [3, 4]. (5) As a result of these studies, the National Cholesterol Education Program (NCEP) published guidelines and defined decisional concentrations for total cholesterol, LDL-C, and HDL-C [5]. It has been postulated for many years that apolipoproteins could be better predictors than lipids for CHD, and many case-control studies have shown that apolipoproteins A-I and B (apo A-I and B) are good